US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alto Neuroscience Inc

25.53

-1.0500-3.95%

Pre-market: 25.530.00000.00%08:19 EDT

Volume:891.62K

Turnover:23.03M

Market Cap:992.36M

PE:-10.72

High:27.41

Open:26.87

Low:25.53

Close:26.58

52wk High:37.48

52wk Low:4.00

Shares:38.87M

Float Shares:29.65M

Volume Ratio:1.42

T/O Rate:3.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3816

EPS(LYR):-2.1918

ROE:-49.17%

ROA:-26.79%

PB:4.53

PE(LYR):-11.65

Loading ...

Overview Company News Filings

Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 Trials

Alto Neuroscience Sets Pricing for $100 Million Registered Direct Offering of Common Stock

Alto Neuroscience prices 3.78M shares at $26.48 in registered direct offering

Alto Neuroscience Plans to Use USD 100 Million Offering Proceeds to Expand Alto-207 Phase 3 Program in Treatment-resistant Depression

Alto Neuroscience - Prices Offering of 3.78 Mln Shares at $26.48 Per Share

THOMSON REUTERS

Alto Neuroscience - Offering Expected to Raise Gross Proceeds of $100 Mln

THOMSON REUTERS

Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock

THOMSON REUTERS

Alto Neuroscience - to Accelerate and Expand Clinical Development of Alto-207 with Additional Planned Phase 3 Trial - SEC Filing

THOMSON REUTERS

Alto Neuroscience Estimates June 30 Cash, Equivalents and Restricted Cash at $244.2 Million

H.C. Wainwright Remains a Buy on Alto Neuroscience, Inc. (ANRO)

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and BridgeBio Pharma (BBIO)

Alto Neuroscience posts investor presentation outlining precision psychiatry pipeline, biomarker-driven drug strategy

Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol

Alto Neuroscience flags Nature Medicine trial showing pramipexole cuts anhedonia symptoms versus placebo

Analysts’ Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), Anixa Biosciences (ANIX)

Alto Neuroscience director Andrew Craig Miller files initial beneficial ownership statement

Alto Neuroscience names Karuna Therapeutics founder Andrew Miller to board

Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.d. to Board of Directors

THOMSON REUTERS

BofA Securities Adjusts Price Target on Alto Neuroscience to $33 From $35

MT Newswires Live

Alto Neuroscience Is Maintained at Outperform by Baird

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ANRO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","market":"US","secType":"STK","nameCN":"Alto Neuroscience Inc","latestPrice":25.53,"timestamp":1790798400000,"preClose":26.58,"halted":0,"volume":891623,"hourTrading":{"tag":"盘前","latestPrice":25.53,"preClose":25.53,"latestTime":"08:19 EDT","volume":595,"amount":15121.513855,"timestamp":1790857186113,"change":0,"changeRate":0,"amplitude":0.042448},"delay":0,"changeRate":-0.03950338600451457,"floatShares":29649500,"shares":38870376,"eps":-2.381577,"marketStatus":"Pre-Mkt","change":-1.05,"latestTime":"10-01 08:58:12 EDT","open":26.87,"high":27.41,"low":25.53,"amount":23025220.637865998,"amplitude":0.07073,"askPrice":28.44,"askSize":100,"bidPrice":25.42,"bidSize":92,"shortable":3,"etf":0,"ttmEps":-2.381577,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"listingDate":1706850000000,"exchange":"NYSE","adjPreClose":25.53,"preHourTrading":{"tag":"盘前","latestPrice":25.53,"preClose":25.53,"latestTime":"08:19 EDT","volume":595,"amount":15121.513855,"timestamp":1790857186113,"change":0,"changeRate":0,"amplitude":0.042448},"postHourTrading":{"tag":"盘后","latestPrice":25.53,"preClose":25.53,"latestTime":"19:30 EDT","volume":11444,"amount":292170.25,"timestamp":1790811007397,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4175552921560397,"impliedVol":0.8409,"impliedVolPercentile":0.516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","floatShares":29649500,"roa":"-26.79%","roe":"-49.17%","lyrEps":-2.191806,"volumeRatio":1.4175552921560397,"shares":38870376,"dividePrice":0,"high":27.41,"amplitude":0.07073,"preClose":26.58,"low":25.53,"week52Low":4,"pbRate":"4.53","week52High":37.48,"institutionHeld":0,"latestPrice":25.53,"committee":-0.041667,"eps":-2.381577,"divideRate":0,"volume":891623,"delay":0,"ttmEps":-2.381577,"open":26.87,"prevYearClose":17.8,"prevWeekClose":26.49,"prevMonthClose":25.53,"prevQuarterClose":25.53,"fiveDayClose":27.5,"twentyDayClose":35.2,"sixtyDayClose":25.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ANRO","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-05-13","symbol":"ANRO","fiscalQuarterEnding":"2026/03","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2026-03-16","symbol":"ANRO","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-11-12","symbol":"ANRO","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"ANRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6364,"buy":0.2727,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6364,"analysts":11,"updateTime":1786766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANRO","date":"2026-09-30","current":-10.719788,"percent":0.150155,"low":-17.068671,"twenty":-11.361501,"median":-7.061183,"eighty":-1.530824,"high":-0.793245,"avg":-6.785981,"sd":4.787512,"marketCap":1043055124},"quantilePoints":[{"date":"2024-02-09","current":-15.481605,"twenty":-16.048587,"median":-15.481605,"eighty":-13.872658,"marketCap":506867732},{"date":"2024-02-16","current":-12.96931,"twenty":-15.548491,"median":-13.234406,"eighty":-11.571235,"marketCap":424615224},{"date":"2024-02-23","current":-10.603839,"twenty":-15.481605,"median":-12.585941,"eighty":-11.026361,"marketCap":347169680},{"date":"2024-03-01","current":-12.56147,"twenty":-14.292343,"median":-12.488059,"eighty":-11.135662,"marketCap":411262544},{"date":"2024-03-08","current":-11.631595,"twenty":-13.230328,"median":-12.361629,"eighty":-11.293904,"marketCap":380818433},{"date":"2024-03-15","current":-12.153631,"twenty":-13.001937,"median":-12.137317,"eighty":-11.306955,"marketCap":397909864},{"date":"2024-03-22","current":-11.14409,"twenty":-12.949734,"median":-12.108768,"eighty":-11.306955,"marketCap":404586204},{"date":"2024-03-28","current":-12.415912,"twenty":-12.956259,"median":-12.145474,"eighty":-11.437463,"marketCap":450759680},{"date":"2024-04-05","current":-10.418119,"twenty":-12.920369,"median":-11.868143,"eighty":-11.162905,"marketCap":378229815},{"date":"2024-04-12","current":-10.440317,"twenty":-12.863272,"median":-11.793418,"eighty":-10.823597,"marketCap":379035702},{"date":"2024-04-19","current":-9.988964,"twenty":-12.713187,"median":-11.631595,"eighty":-10.532067,"marketCap":362649325},{"date":"2024-04-26","current":-10.455115,"twenty":-12.538631,"median":-11.566341,"eighty":-10.461035,"marketCap":379572960},{"date":"2024-05-03","current":-10.654895,"twenty":-12.497847,"median":-11.513206,"eighty":-10.478793,"marketCap":386825947},{"date":"2024-05-10","current":-10.802879,"twenty":-12.4592,"median":-11.360121,"eighty":-10.478793,"marketCap":392198529},{"date":"2024-05-17","current":-8.114957,"twenty":-12.377436,"median":-11.191128,"eighty":-10.431438,"marketCap":344382544},{"date":"2024-05-24","current":-7.443985,"twenty":-12.295701,"median":-11.079356,"eighty":-10.270134,"marketCap":315907856},{"date":"2024-05-31","current":-7.59948,"twenty":-12.254775,"median":-10.943138,"eighty":-9.999323,"marketCap":322506720},{"date":"2024-06-07","current":-7.453823,"twenty":-12.218885,"median":-10.773282,"eighty":-9.088414,"marketCap":316325341},{"date":"2024-06-14","current":-7.612146,"twenty":-12.153631,"median":-10.654895,"eighty":-8.114957,"marketCap":323044231},{"date":"2024-06-21","current":-6.997854,"twenty":-12.14058,"median":-10.580902,"eighty":-7.890353,"marketCap":296974938},{"date":"2024-06-28","current":-6.731872,"twenty":-12.125897,"median":-10.558705,"eighty":-7.854905,"marketCap":285687202},{"date":"2024-07-05","current":-7.35883,"twenty":-12.080219,"median":-10.514309,"eighty":-7.738804,"marketCap":312294007},{"date":"2024-07-12","current":-8.486086,"twenty":-11.912764,"median":-10.492111,"eighty":-7.738804,"marketCap":360132504},{"date":"2024-07-15","current":-8.840728,"twenty":-11.90384,"median":-10.492111,"eighty":-7.738804,"marketCap":375182817},{"date":"2024-08-02","current":-6.212575,"twenty":-11.894916,"median":-10.481012,"eighty":-7.674208,"marketCap":263649243},{"date":"2024-08-09","current":-5.762939,"twenty":-11.86488,"median":-10.440317,"eighty":-7.584281,"marketCap":244567596},{"date":"2024-08-16","current":-5.077305,"twenty":-11.842621,"median":-10.421819,"eighty":-7.439715,"marketCap":252875166},{"date":"2024-08-23","current":-5.770157,"twenty":-11.798049,"median":-10.270134,"eighty":-7.320833,"marketCap":287382652},{"date":"2024-08-30","current":-6.766131,"twenty":-11.747422,"median":-10.066655,"eighty":-7.023186,"marketCap":336987162},{"date":"2024-09-06","current":-6.885215,"twenty":-11.696849,"median":-9.985264,"eighty":-6.997854,"marketCap":342918136},{"date":"2024-09-13","current":-7.036776,"twenty":-11.629964,"median":-9.589405,"eighty":-7.005638,"marketCap":350466649},{"date":"2024-09-20","current":-7.269531,"twenty":-11.615282,"median":-8.800669,"eighty":-7.041657,"marketCap":362059007},{"date":"2024-09-27","current":-6.495486,"twenty":-11.576129,"median":-8.327763,"eighty":-6.997854,"marketCap":323507676},{"date":"2024-10-04","current":-5.51575,"twenty":-11.542663,"median":-8.073812,"eighty":-6.792939,"marketCap":274711934},{"date":"2024-10-11","current":-6.392641,"twenty":-11.505807,"median":-7.947789,"eighty":-6.506312,"marketCap":318385471},{"date":"2024-10-18","current":-7.724215,"twenty":-11.453451,"median":-7.863613,"eighty":-6.586066,"marketCap":384704544},{"date":"2024-10-25","current":-2.23553,"twenty":-11.361501,"median":-7.821648,"eighty":-6.506312,"marketCap":111340558},{"date":"2024-10-31","current":-2.181401,"twenty":-11.357822,"median":-7.776801,"eighty":-6.403467,"marketCap":108644661},{"date":"2024-11-08","current":-2.083968,"twenty":-11.223755,"median":-7.738804,"eighty":-6.212575,"marketCap":103792046},{"date":"2024-11-15","current":-2.159604,"twenty":-11.191128,"median":-7.724215,"eighty":-6.11117,"marketCap":124062772},{"date":"2024-11-22","current":-1.92017,"twenty":-11.14409,"median":-7.634377,"eighty":-5.98126,"marketCap":110307987},{"date":"2024-11-29","current":-2.070403,"twenty":-11.113816,"median":-7.615312,"eighty":-5.768005,"marketCap":118938440},{"date":"2024-12-06","current":-1.830969,"twenty":-11.06322,"median":-7.574148,"eighty":-5.648645,"marketCap":105183655},{"date":"2024-12-13","current":-1.798105,"twenty":-11.000259,"median":-7.504253,"eighty":-5.44863,"marketCap":103295743},{"date":"2024-12-20","current":-1.746462,"twenty":-10.916697,"median":-7.443985,"eighty":-5.07514,"marketCap":100329024},{"date":"2024-12-27","current":-2.075098,"twenty":-10.841355,"median":-7.436869,"eighty":-2.363274,"marketCap":119208142},{"date":"2025-01-03","current":-2.056319,"twenty":-10.79104,"median":-7.390494,"eighty":-2.255016,"marketCap":118129335},{"date":"2025-01-10","current":-2.070403,"twenty":-10.767363,"median":-7.35883,"eighty":-2.165554,"marketCap":118938440},{"date":"2025-01-17","current":-2.079793,"twenty":-10.725927,"median":-7.312287,"eighty":-2.141345,"marketCap":119477844},{"date":"2025-01-24","current":-2.272279,"twenty":-10.654895,"median":-7.277651,"eighty":-2.138097,"marketCap":130535613},{"date":"2025-01-31","current":-2.093877,"twenty":-10.603839,"median":-7.253293,"eighty":-2.122046,"marketCap":120286949},{"date":"2025-02-07","current":-1.854443,"twenty":-10.580902,"median":-7.17813,"eighty":-2.093877,"marketCap":106532163},{"date":"2025-02-14","current":-1.530502,"twenty":-10.558705,"median":-7.145034,"eighty":-2.075098,"marketCap":87922747},{"date":"2025-02-21","current":-1.464775,"twenty":-10.529107,"median":-7.061183,"eighty":-2.070403,"marketCap":84146924},{"date":"2025-02-28","current":-1.305152,"twenty":-10.515789,"median":-6.997854,"eighty":-2.041295,"marketCap":74977067},{"date":"2025-03-07","current":-1.854443,"twenty":-10.50839,"median":-6.933931,"eighty":-2.023455,"marketCap":106532163},{"date":"2025-03-14","current":-1.483554,"twenty":-10.495071,"median":-6.768,"eighty":-2.01289,"marketCap":85225730},{"date":"2025-03-21","current":-1.180996,"twenty":-10.492111,"median":-6.549615,"eighty":-1.993408,"marketCap":72549751},{"date":"2025-03-28","current":-1.062067,"twenty":-10.474353,"median":-6.422411,"eighty":-1.971812,"marketCap":65243830},{"date":"2025-04-04","current":-0.81528,"twenty":-10.458075,"median":-6.392641,"eighty":-1.92017,"marketCap":50083438},{"date":"2025-04-11","current":-0.903418,"twenty":-10.443277,"median":-6.253891,"eighty":-1.873222,"marketCap":55497864},{"date":"2025-04-17","current":-0.991556,"twenty":-10.440317,"median":-6.19297,"eighty":-1.833785,"marketCap":60912290},{"date":"2025-04-25","current":-1.004777,"twenty":-10.431438,"median":-6.11117,"eighty":-1.798105,"marketCap":61724454},{"date":"2025-05-02","current":-1.079695,"twenty":-10.421079,"median":-6.037568,"eighty":-1.742706,"marketCap":66326716},{"date":"2025-05-09","current":-0.965115,"twenty":-10.40924,"median":-5.975847,"eighty":-1.645994,"marketCap":59287962},{"date":"2025-05-16","current":-1.041186,"twenty":-10.323409,"median":-5.766106,"eighty":-1.583083,"marketCap":65785273},{"date":"2025-05-23","current":-1.255422,"twenty":-10.270134,"median":-5.686944,"eighty":-1.500455,"marketCap":79321337},{"date":"2025-05-30","current":-1.152589,"twenty":-10.199102,"median":-5.617282,"eighty":-1.480737,"marketCap":72824027},{"date":"2025-06-06","current":-1.019763,"twenty":-10.071835,"median":-5.469741,"eighty":-1.461958,"marketCap":64431667},{"date":"2025-06-13","current":-1.049756,"twenty":-10.02004,"median":-5.30697,"eighty":-1.408438,"marketCap":66326716},{"date":"2025-06-20","current":-0.972631,"twenty":-9.987484,"median":-5.077305,"eighty":-1.322054,"marketCap":61453732},{"date":"2025-06-27","current":-0.985485,"twenty":-9.980084,"median":-2.492642,"eighty":-1.263991,"marketCap":62265896},{"date":"2025-07-03","current":-1.006909,"twenty":-9.974165,"median":-2.341082,"eighty":-1.221144,"marketCap":63619503},{"date":"2025-07-11","current":-1.105457,"twenty":-9.589405,"median":-2.272279,"eighty":-1.163435,"marketCap":69846092},{"date":"2025-07-18","current":-1.233999,"twenty":-8.963166,"median":-2.213594,"eighty":-1.13545,"marketCap":77967731},{"date":"2025-07-25","current":-1.319693,"twenty":-8.840728,"median":-2.178383,"eighty":-1.148304,"marketCap":83382157},{"date":"2025-08-01","current":-1.315408,"twenty":-8.760609,"median":-2.161951,"eighty":-1.152589,"marketCap":83111436},{"date":"2025-08-08","current":-1.311123,"twenty":-8.486086,"median":-2.154336,"eighty":-1.163435,"marketCap":82840714},{"date":"2025-08-15","current":-1.302504,"twenty":-8.327763,"median":-2.124393,"eighty":-1.163435,"marketCap":84479082},{"date":"2025-08-22","current":-1.498714,"twenty":-8.182106,"median":-2.122046,"eighty":-1.165443,"marketCap":97205098},{"date":"2025-08-29","current":-1.590557,"twenty":-8.114957,"median":-2.098572,"eighty":-1.169728,"marketCap":103161956},{"date":"2025-09-05","current":-1.465317,"twenty":-8.049126,"median":-2.084227,"eighty":-1.178742,"marketCap":95038967},{"date":"2025-09-12","current":-1.640654,"twenty":-7.979964,"median":-2.075098,"eighty":-1.18912,"marketCap":106411151},{"date":"2025-09-19","current":-1.715798,"twenty":-7.951589,"median":-2.070403,"eighty":-1.198007,"marketCap":111284945},{"date":"2025-09-26","current":-1.586383,"twenty":-7.904286,"median":-2.056319,"eighty":-1.216859,"marketCap":102891190},{"date":"2025-10-03","current":-1.841039,"twenty":-7.881184,"median":-2.039887,"eighty":-1.228,"marketCap":119407933},{"date":"2025-10-10","current":-2.513164,"twenty":-7.867586,"median":-2.056319,"eighty":-1.233142,"marketCap":163001306},{"date":"2025-10-17","current":-2.454718,"twenty":-7.85227,"median":-2.070403,"eighty":-1.244282,"marketCap":159210578},{"date":"2025-10-24","current":-4.667305,"twenty":-7.827138,"median":-2.075098,"eighty":-1.253708,"marketCap":302716712},{"date":"2025-10-31","current":-5.978158,"twenty":-7.812987,"median":-2.084227,"eighty":-1.2897,"marketCap":387737327},{"date":"2025-11-07","current":-4.646431,"twenty":-7.783605,"median":-2.103267,"eighty":-1.301657,"marketCap":301362880},{"date":"2025-11-14","current":-4.738274,"twenty":-7.773873,"median":-2.122046,"eighty":-1.304622,"marketCap":307319739},{"date":"2025-11-21","current":-7.060871,"twenty":-7.758215,"median":-2.12674,"eighty":-1.306199,"marketCap":439588640},{"date":"2025-11-28","current":-6.91117,"twenty":-7.745076,"median":-2.154336,"eighty":-1.306688,"marketCap":430268739},{"date":"2025-12-05","current":-6.67664,"twenty":-7.738804,"median":-2.161951,"eighty":-1.306839,"marketCap":415667562},{"date":"2025-12-12","current":-7.325342,"twenty":-7.736546,"median":-2.178383,"eighty":-1.309247,"marketCap":456053797},{"date":"2025-12-19","current":-9.705579,"twenty":-7.761946,"median":-2.213594,"eighty":-1.311015,"marketCap":604240215},{"date":"2025-12-26","current":-9.920149,"twenty":-7.817318,"median":-2.253904,"eighty":-1.311123,"marketCap":617598739},{"date":"2026-01-02","current":-8.882226,"twenty":-7.875492,"median":-2.303191,"eighty":-1.311123,"marketCap":552980763},{"date":"2026-01-09","current":-7.929133,"twenty":-7.944058,"median":-2.354526,"eighty":-1.311807,"marketCap":493644063},{"date":"2026-01-16","current":-8.493005,"twenty":-8.098499,"median":-2.410079,"eighty":-1.314542,"marketCap":528749021},{"date":"2026-01-23","current":-8.572845,"twenty":-8.233524,"median":-2.467243,"eighty":-1.314542,"marketCap":533719635},{"date":"2026-01-30","current":-7.644703,"twenty":-8.248494,"median":-2.550736,"eighty":-1.315408,"marketCap":475936252},{"date":"2026-02-06","current":-7.040911,"twenty":-8.233524,"median":-2.675047,"eighty":-1.315408,"marketCap":438345986},{"date":"2026-02-13","current":-8.203584,"twenty":-8.278435,"median":-4.258185,"eighty":-1.315408,"marketCap":510730547},{"date":"2026-02-20","current":-9.730529,"twenty":-8.329873,"median":-4.59216,"eighty":-1.315408,"marketCap":605793532},{"date":"2026-02-27","current":-9.625739,"twenty":-8.433125,"median":-4.619295,"eighty":-1.315408,"marketCap":599269602},{"date":"2026-03-06","current":-10.26945,"twenty":-8.504981,"median":-4.688178,"eighty":-1.318836,"marketCap":639345174},{"date":"2026-03-13","current":-11.092803,"twenty":-8.596797,"median":-4.780021,"eighty":-1.319693,"marketCap":690604627},{"date":"2026-03-20","current":-10.997993,"twenty":-8.80207,"median":-5.077305,"eighty":-1.323121,"marketCap":684702023},{"date":"2026-03-27","current":-10.5175,"twenty":-8.978914,"median":-5.159821,"eighty":-1.327405,"marketCap":665105643},{"date":"2026-04-02","current":-11.825873,"twenty":-9.157675,"median":-5.286907,"eighty":-1.342565,"marketCap":747844529},{"date":"2026-04-10","current":-11.315658,"twenty":-9.59795,"median":-5.418318,"eighty":-1.358364,"marketCap":715579558},{"date":"2026-04-17","current":-14.44502,"twenty":-9.715559,"median":-5.499511,"eighty":-1.373177,"marketCap":913474169},{"date":"2026-04-24","current":-14.251015,"twenty":-9.940109,"median":-5.617282,"eighty":-1.380269,"marketCap":901205714},{"date":"2026-05-01","current":-14.2233,"twenty":-9.993374,"median":-5.686437,"eighty":-1.40625,"marketCap":899453077},{"date":"2026-05-08","current":-13.341966,"twenty":-10.092797,"median":-5.762939,"eighty":-1.428579,"marketCap":843719235},{"date":"2026-05-15","current":-11.128225,"twenty":-10.269724,"median":-5.815711,"eighty":-1.431919,"marketCap":826893924},{"date":"2026-05-22","current":-10.161169,"twenty":-10.270134,"median":-5.928061,"eighty":-1.443182,"marketCap":755035825},{"date":"2026-05-29","current":-9.538479,"twenty":-10.26986,"median":-5.978158,"eighty":-1.454447,"marketCap":708766220},{"date":"2026-06-05","current":-9.448849,"twenty":-10.241369,"median":-6.015388,"eighty":-1.46008,"marketCap":702106201},{"date":"2026-06-12","current":-10.121163,"twenty":-10.184016,"median":-6.089518,"eighty":-1.46008,"marketCap":752063134},{"date":"2026-06-18","current":-10.291187,"twenty":-10.191631,"median":-6.176125,"eighty":-1.461019,"marketCap":764696952},{"date":"2026-06-26","current":-11.948923,"twenty":-10.281083,"median":-6.203076,"eighty":-1.464883,"marketCap":887876682},{"date":"2026-07-02","current":-11.778899,"twenty":-10.355847,"median":-6.327685,"eighty":-1.465317,"marketCap":875242863},{"date":"2026-07-10","current":-13.05408,"twenty":-10.419151,"median":-6.392641,"eighty":-1.474164,"marketCap":969996501},{"date":"2026-07-17","current":-14.296657,"twenty":-10.441725,"median":-6.422411,"eighty":-1.474164,"marketCap":1062327376},{"date":"2026-07-24","current":-14.045563,"twenty":-10.492111,"median":-6.506979,"eighty":-1.478859,"marketCap":1043669595},{"date":"2026-07-31","current":-14.976703,"twenty":-10.518342,"median":-6.61177,"eighty":-1.482615,"marketCap":1112858864},{"date":"2026-08-07","current":-14.893005,"twenty":-10.61405,"median":-6.65169,"eighty":-1.485663,"marketCap":1106639604},{"date":"2026-08-14","current":-15.04689,"twenty":-10.749604,"median":-6.68163,"eighty":-1.487837,"marketCap":1267519959},{"date":"2026-08-21","current":-15.955294,"twenty":-10.831771,"median":-6.749002,"eighty":-1.49576,"marketCap":1344042062},{"date":"2026-08-28","current":-16.910282,"twenty":-10.954971,"median":-6.885215,"eighty":-1.498499,"marketCap":1424488375},{"date":"2026-09-04","current":-16.956867,"twenty":-11.008887,"median":-6.91117,"eighty":-1.501609,"marketCap":1428412585},{"date":"2026-09-11","current":-14.758065,"twenty":-11.106858,"median":-6.950061,"eighty":-1.502667,"marketCap":1243189854},{"date":"2026-09-18","current":-14.431971,"twenty":-11.171055,"median":-6.997854,"eighty":-1.505393,"marketCap":1215720381},{"date":"2026-09-25","current":-12.661749,"twenty":-11.331823,"median":-7.050891,"eighty":-1.521126,"marketCap":1066600386},{"date":"2026-09-30","current":-12.38224,"twenty":-11.361501,"median":-7.061183,"eighty":-1.530824,"marketCap":1043055124}],"updateTime":1790854729366},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANRO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651911466","title":"Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2651911466","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651911466?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:51","pubTimestamp":1783947100,"startTime":"0","endTime":"0","summary":"Alto Neuroscience, Inc. ( ($ANRO) ) has provided an announcement. On July 13, 2026, Alto Neuroscience, Inc. reported preliminary estimates that its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alto-neuroscience-highlights-strong-cash-expands-alto-207-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alto-neuroscience-highlights-strong-cash-expands-alto-207-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANRO","BK4109","BK4007","ALTO","BK4138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136207166","title":"Alto Neuroscience Sets Pricing for $100 Million Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1136207166","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136207166?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:50","pubTimestamp":1783947040,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company Alto Neuroscience Inc has announced the pricing of its underwritten registered direct public offering.The offering consists of 3,776,436 shares of common...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651199141","title":"Alto Neuroscience prices 3.78M shares at $26.48 in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2651199141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651199141?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:56","pubTimestamp":1783943760,"startTime":"0","endTime":"0","summary":"Alto Neuroscience (ANRO) announced the pricing of an underwritten registered direct offering of 3,776,436 shares of its common stock at a price of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-prices-3-78m-shares-at-26-48-in-registered-direct-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-prices-3-78m-shares-at-26-48-in-registered-direct-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651027116","title":"Alto Neuroscience Plans to Use USD 100 Million Offering Proceeds to Expand Alto-207 Phase 3 Program in Treatment-resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2651027116","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651027116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:47","pubTimestamp":1783943256,"startTime":"0","endTime":"0","summary":"Alto Neuroscience plans to use USD 100 million offering proceeds to expand ALTO-207 Phase 3 program in treatment-resistant depressionAlto Neuroscience plans to use new capital to accelerate and expand","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL68Skpp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116044","title":"Alto Neuroscience - Prices Offering of 3.78 Mln Shares at $26.48 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651116044?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:47","pubTimestamp":1783943220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA9N5JGV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116041","title":"Alto Neuroscience - Offering Expected to Raise Gross Proceeds of $100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651116041?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:47","pubTimestamp":1783943220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA9N5JGV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651040116","title":"Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2651040116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651040116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:47","pubTimestamp":1783943220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA9N5JGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651755116","title":"Alto Neuroscience - to Accelerate and Expand Clinical Development of Alto-207 with Additional Planned Phase 3 Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651755116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651755116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:40","pubTimestamp":1783942823,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0C7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651757116","title":"Alto Neuroscience Estimates June 30 Cash, Equivalents and Restricted Cash at $244.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651757116","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651757116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:40","pubTimestamp":1783942819,"startTime":"0","endTime":"0","summary":"Alto Neuroscience estimates June 30 cash, equivalents and restricted cash at $244.2 millionAlto Neuroscience estimated cash, cash equivalents, restricted cash of about USD 244.2 million as of June 30,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2QD8ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646808149","title":"H.C. Wainwright Remains a Buy on Alto Neuroscience, Inc. (ANRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646808149","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646808149?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:36","pubTimestamp":1782390982,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Alto Neuroscience, Inc., with a price target of $50.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643420701","title":"Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643420701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643420701?lang=en_us&edition=fundamental","pubTime":"2026-06-16 01:10","pubTimestamp":1781543448,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alto Neuroscience, Inc. (ANRO) and BridgeBio Pharma ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4139","ANRO","BBIO","XBI","XLV","BK4007","HCSG","BK4585","BK4505","BK4581","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643204712","title":"Alto Neuroscience posts investor presentation outlining precision psychiatry pipeline, biomarker-driven drug strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2643204712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643204712?lang=en_us&edition=fundamental","pubTime":"2026-06-15 23:28","pubTimestamp":1781537293,"startTime":"0","endTime":"0","summary":"Alto Neuroscience outlined a biomarker-driven precision psychiatry strategy to target responsive patient groups earlier in development.ALTO-207 for treatment-resistant depression: Phase 2b ongoing; Phase 3 initiation planned by early 2027; Phase 2b topline data expected in 2H 2027.ALTO-300 for major depressive disorder: Phase 2b ongoing; topline data expected in 1H 2027; ALTO-208 bipolar depression readout targeted for mid-2027.Company forecast an expected cash runway through 2029; highlighted four late-stage data readouts over the next about three years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alto Neuroscience Inc. published the original content used to generate this news brief on June 15, 2026, and is solely responsible for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL2GwDHx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203280","title":"Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203280?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:16","pubTimestamp":1781525781,"startTime":"0","endTime":"0","summary":"Alto Neuroscience (ANRO) highlighted the publication in Nature Medicine of Prime-Praxol, an independent, randomized, double-blind, placebo-controll...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-highlights-publication-in-nature-medicine-on-prime-praxol-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-highlights-publication-in-nature-medicine-on-prime-praxol-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203537","title":"Alto Neuroscience flags Nature Medicine trial showing pramipexole cuts anhedonia symptoms versus placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203537?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:05","pubTimestamp":1781525120,"startTime":"0","endTime":"0","summary":"Alto Neuroscience highlighted a newly published Nature Medicine trial showing pramipexole reduced anhedonia versus placebo in mood-disorder patients.Benefits also showed up on separate measures of anhedonia and apathy, with effects maintained through a six-month open-label extension.Post-hoc findings indicated patients with major depressive disorder improved more than those with dysthymia, pointing to a clearer target population.High nausea rates in the pramipexole arm underscored tolerability limits that ALTO-207 aims to address by pairing pramipexole with ondansetron.A potentially pivotal Phase 2b trial of ALTO-207 in treatment-resistant depression is ongoing, with data expected in 2H 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL3WLyYx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642287216","title":"Analysts’ Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), Anixa Biosciences (ANIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642287216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642287216?lang=en_us&edition=fundamental","pubTime":"2026-06-11 21:30","pubTimestamp":1781184614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alto Neuroscience, Inc. (ANRO), Anixa Biosciences (A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alto-neuroscience-inc-anro-anixa-biosciences-anix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alto-neuroscience-inc-anro-anixa-biosciences-anix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","XLV","BK4137","ANIX","BK4588","BK4585","HCSG","LABU","BK4139","BK4007","LU0029874061.USD","ANRO","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639720326","title":"Alto Neuroscience director Andrew Craig Miller files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2639720326","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639720326?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:16","pubTimestamp":1780085799,"startTime":"0","endTime":"0","summary":"Alto Neuroscience director Andrew Craig Miller filed an initial Form 3 on May 29 covering the May 27 reporting date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alto Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLvm1VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698274","title":"Alto Neuroscience names Karuna Therapeutics founder Andrew Miller to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698274","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698274?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:07","pubTimestamp":1779970072,"startTime":"0","endTime":"0","summary":"Alto Neuroscience named Andrew Miller to its board, effective May 27, 2026.Miller founded Karuna Therapeutics. He led R&D. He also served as CEO and COO. Karuna sold to Bristol Myers Squibb for $14 billion in 2024.He was lead inventor of KarXT, now marketed by Bristol Myers Squibb as COBENFY for schizophrenia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL6TYBPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0432979614.USD","LU0237698245.USD","LU0306806265.USD","LU1883839398.USD","LU2133065610.SGD","IE00BJJMRZ35.SGD","BK4588","LU1261432733.SGD","LU1670711040.USD","ANRO","LU1323610961.USD","LU2125154778.USD","BK4585","BMY","LU2242652126.USD","LU0306807586.USD","BK4559","LU0985481810.HKD","LU0321505439.SGD","IE00BSNM7G36.USD","BK4581","LU0882574055.USD","LU1032466523.USD","IE0009355771.USD","LU1571399168.USD","LU1718418525.SGD","LU1983299246.USD","LU1585245621.USD","LU1670710661.SGD","LU0225771236.USD","LU0321505868.SGD","LU0868494617.USD","BK4007","LU1670710588.SGD","LU2125154935.USD","LU2360032135.SGD","LU1093756168.USD","LU1868837300.USD","LU1989771016.USD","LU1868836757.USD","LU1430594728.SGD","LU1868836914.USD","LU0061475181.USD","LU0267386448.USD","IE00BFTCPJ56.SGD","LU1074936037.SGD","LU1670711123.USD","LU0225284248.USD","LU1868836591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638981076","title":"Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.d. to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2638981076","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638981076?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:03","pubTimestamp":1779969780,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUAKZBMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637431152","title":"BofA Securities Adjusts Price Target on Alto Neuroscience to $33 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2637431152","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637431152?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:12","pubTimestamp":1779451948,"startTime":"0","endTime":"0","summary":"Alto Neuroscience (ANRO) has an average rating of buy and mean price target of $35.11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700831","title":"Alto Neuroscience Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700831","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636700831?lang=en_us&edition=fundamental","pubTime":"2026-05-19 01:15","pubTimestamp":1779124500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 13:15 ET (17:15 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":90,"code":"91000000","status":"200"}]}}